Latest Tobacco cessation Stories
PARSIPPANY, N.J., July 1 - Data published in the journal, Nicotine and Tobacco Research, shows that many U.S. quit attempts are unplanned and can be a successful route to cessation.
The U.S. Food and Drug Administration announced Wednesday it will require a boxed warning for the smoking cessation drugs Chantix and Zyban. The FDA said the boxed warning -- the strongest warning the agency can require -- will appear on the package insert.
TBWA assigned alli and Smoking Control Grey assigned US brands TUMS, Citrucel and FiberChoice PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare) (NYSE: GSK) has announced advertising agency changes to support growth for global brands.
Preliminary results of a new study suggest that pregnant women who are also substance-dependent and smoke cigarettes may significantly benefit from certain antidepressant drugs.
Doctors who really want to help their patients kick the habit need to get aggressive.
Smokers who do not want to quit, but want to cut down, are twice as likely to stop smoking if they use nicotine replacement therapy, British researchers said.
The FDA is warning that medication and nicotine patches could burn the skin of patients during an MRI scan.
People with a likely history of depression who take varenicline (ChantixÂ®) do not report more severe mood symptoms, medication side effects, or less success quitting smoking compared to people with no history of depression taking this drug.
A popular smoking cessation drug dramatically reduced the amount a heavy drinker will consume, a new Yale School of Medicine study has found.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.